SeniorJournal.com - Daily News for Senior Citizens

  FRONT PAGE • Aging • Health • Alzheimer's - Mental • Nutrition • Medicare & Medicaid • Politics  • Fitness  • Social Security • Alerts • Sex Health • Features • Retirement • Elder Care  >Search  >Senior Links

[NavBar.htm]

Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers

More Senior Citizen News and Information Than Any Other Source - SeniorJournal.com

• Go to more on Health & Medicine or More Senior News from SeniorJournal.com on the Front Page

 
 
Follow on  and 

E-mail this page to a friend!

Health & Medicine for Senior Citizens

Prostate Cancer Patients Receiving ADT Should be Counseled to Improve Mental Well-Being

Previous studies have reported cognitive and affective symptoms following ADT, particularly in the elderly

Jan. 24, 2014 – A new study published in the Journal of Urology reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life two years after treatment. Previous studies have reported cognitive and affective symptoms following ADT, particularly in the elderly. Symptoms include emotional upset (tearfulness, irritability, and anger), decreased motivation, hopelessness, and cognitive interruptions in attention, memory, and visual processing.

Investigators at the University of California-San Francisco recommend counseling men about the potential adverse effects of ADT as well as the interventions to improve mental and emotional health such as exercise programs and diet.

 

Related Archive Stories

 
 

What are Chances Your Prostate Cancer Test has been Overdiagnosed? New Tool Can Tell You

Nomogram aims to enable informed decision-making and personalized treatment; a graphical calculating device using patient's age, PSA level and Gleason score

Jan. 11, 2014

Longer Survival of Metastatic Prostate Cancer Patients Using Docetaxel Prompts Data Release

Three-year survival rate of 69 percent when chemotherapy drug docetaxel given at start of standard hormone therapy

Dec. 6, 2013

Carbon Monoxide Prevents Growth in Prostate, Lung Tumors; Enhances Chemotherapy

Opens possibility of new cancer therapy to take advantage of powerful chemotherapy drugs making them more potent and limiting terrible side effects, damage to normal cells

Dec. 4, 2013

Drug Tasquinimod May Improve Survival in Men with Metastatic Prostate Cancer

An oral therapy that activates the body's immune system to fight cancer, also known to block tumor blood vessel growth

Nov. 19, 2013

Overweight Men Much Less Likely to Survive Diagnosis of Prostate Cancer

Men who died from prostate cancer were 50% more likely to be overweight or obese at diagnosis

Oct. 30, 2013

Lung, Prostate and Other Cancers Diagnosed by Simple Blood Test, Researchers Say

'we identified compounds that appear to be new screening biomarkers in cancer diagnosis and prognosis'

October 15, 2013

Why Do They Keep Screening 75-Year-Olds for Cancer When They Are Not Supposed To?

As a 75-year-old I have an opinion on this new JAMA study finding docs keep on doing PSA screening for old guys despite the experts advising against it - Oct. 15, 2013

By Tucker Sutherland, editor, SeniorJournal.com

New Urine Test for Prostate Cancer Hailed as Best Ever and Easily Available by Mail

Research shows the two-marker urine test is more effective than PSA test alone, or PSA testing that’s incorporated into a commonly used online tool - the Prostate Cancer Risk Calculator

Sept. 25, 2013

Most Older Men Say They Want Prostate Cancer Test Despite Risks, Task Force Objections

Although experts say middle-aged men should not have routine PSA tests, majority of older men disagree, especially those of higher income, black or had recent test - July 11, 2013


 
 

Read the latest news
> Health & Medicine
>
Today's Headlines

 

Nearly 240,000 men were expected to be diagnosed with prostate cancer in the United States in 2013, with around 30,000 deaths. Treatment for prostate cancer is associated with significant physical side-effects.

Age is the most important risk factor for prostate cancer. The disease is extremely rare in men under age 40, but the risk increases greatly with age. More than 60 percent of cases are diagnosed in men over age 65. The average age at the time of diagnosis is 65.

Some of these patients are likely to experience more adverse side-effects and complications from the treatment than from the cancer itself. Earlier studies have suggested that treatment may also affect mental and emotional health.

ADT, which suppresses the production of testosterone by either medical or surgical castration, remains the gold standard for treating advanced prostate cancer, either alone or with radiation therapy. Benefits include reduction of tumor burden, delayed cancer progression, and overall improvement in survival in some cases.

However, ADT has a number of physical side-effects, including hot flashes, decreased libido, fatigue, decreased bone and muscle mass, increased total body fat content, and possible harmful cardiovascular effects.

Some studies have linked ADT use to depression, although it is not clear whether such effects are a direct consequence of ADT itself or perhaps associated with age, comorbidities, hot flashes, fatigue, and insomnia.

The current authors evaluated the effects of ADT on mental and emotional well-being in men diagnosed with localized prostate cancer using data from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry, which consists of data from largely community-based practices across the United States. Over 3,000 men completed a pretreatment and at least one posttreatment quality of life assessment checklist.

The authors focused on men newly diagnosed with localized (non-metastatic) prostate cancer in 1995-2011 and treated with radical prostatectomy, brachytherapy, radiation therapy, or primary androgen deprivation therapy (PADT).

Of men included in the study 75% were treated with local therapy, 20% combination treatment, and five percent PADT. Among men in the PADT group, 84% were treated with luteinizing hormone-releasing hormone agonist monotherapy and 16% received combined androgen blockade.

Approximately 36% of patients reported some type of mental impairment at pretreatment evaluation, including depression, insomnia, confusion, poor concentration, sleep disturbances, nervousness, or poor memory. There were no overall differences in rates of mental health symptoms at diagnosis among treatment groups, although 18% of the PADT group reported poorer memory compared to 12% in the local group and 15% in the combination group.

Analysis demonstrated that exposure to ADT was associated with significant changes in mental and emotional well-being but did not result in clinically meaningful declines at 24 months. "These results could be related to men in the ADT group adapting to their symptoms over time, thus reporting improves scores," explains lead investigator Clint Cary, MD, MPH, of the Department of Urology at the University of California-San Francisco.

The most pronounced effect of ADT was on vitality. "This result corroborates other studies documenting fatigue among the most commonly reported side effects of ADT," says Cary. "It is not clear though whether the fatigue is a direct effect of ADT itself or a consequence of the physical side effects of ADT, such as sleep disturbances or hot flashes."

Cary recommends that patients are counseled on possible ADT-related quality of life changes, as well as ways to minimize these changes before treatment for prostate cancer. "All patients should be well informed about the potential adverse effects of ADT, and interventions to improve mental and emotional health such as exercise programs and dietary/lifestyles changes could be of particular importance," he concludes.

 

> Medical Malpractice,

> Nursing Home Abuse,

> Personal Injury

Our Experienced Lawyers Can Help

Beth Janicek, Board Certified Personal Injury Attorney"We win because we care, we prepare and we have no fear," Beth Janicek, board certified personal injury attorney

 

Free Consultation on your case.

Call Now Toll Free

1-877-795-3425

or Send Email

More at our Website

 

 

Search for more about this topic on SeniorJournal.com

Google Web SeniorJournal.com

Keep up with the latest news for senior citizens, baby boomers

 

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

    

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, SASeniors.com, DrugDanger.com, etc.